» Articles » PMID: 16014096

Chronic Kidney Disease in Costa Rica

Overview
Specialty Nephrology
Date 2005 Jul 15
PMID 16014096
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Costa Rica is one of the Central American countries, located between Nicaragua to the north and Panama to the south. Like other Latin American countries, Costa Rica deals with social and economic problems associated with poverty, except for one significant difference-Costa Rica has not had an army since 1948, and so the people and government can spend more money on education and health. For this reason, Costa Rica is very different from other Latin American countries. We do not need weapons, and we have had a democratic tradition for 100 years. Despite our economic and social limitations, Costa Ricans have universal access to a health system that covers 98% of the inhabitants. Renal replacement therapy (RRT) is accessible to all who need it. In the last 5 years, Costa Rica has doubled the number of patients on hemodialysis, and has the highest number of kidney transplants per million population (pmp) in Latin America, with 20.63 transplants pmp in 2000, 27.25 transplants pmp in 2001, and 24.81 transplants pmp in 2002. However, the prevalence of all forms of RRT in Costa Rica is currently 193 pmp. This suggests that end-stage renal disease is underdiagnosed in Costa Rica as it is in many other Latin American countries. Greater research efforts are needed to determine the true extent of renal disease in Costa Rica and to optimize the use of health-sector resources to provide a better and more robust program of RRT for patients with end-stage renal disease.

Citing Articles

Longitudinal leucocyte DNA methylation changes in Mesoamerican nephropathy.

Oomatia A, Chervova O, Al-Rashed A, Smpokou E, Ecker S, Pearce N Environ Epigenet. 2025; 11(1):dvaf001.

PMID: 39917055 PMC: 11801219. DOI: 10.1093/eep/dvaf001.


Chronic Kidney Disease of Unknown Etiology: A Global Health Threat in Rural Agricultural Communities-Prevalence, Suspected Causes, Mechanisms, and Prevention Strategies.

Ben Khadda Z, Lahmamsi H, El Karmoudi Y, Ezrari S, El Hanafi L, Houssaini T Pathophysiology. 2024; 31(4):761-786.

PMID: 39728687 PMC: 11677577. DOI: 10.3390/pathophysiology31040052.


Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA.

Nkunu V, Tungsanga S, Diongole H, Sarki A, Arruebo S, Caskey F PLOS Glob Public Health. 2024; 4(12):e0003979.

PMID: 39621612 PMC: 11611141. DOI: 10.1371/journal.pgph.0003979.


Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Calice-Silva V, Neyra J, Ferreiro Fuentes A, Singer Wallbach Massai K, Arruebo S, Bello A Kidney Int Suppl (2011). 2024; 13(1):43-56.

PMID: 38618500 PMC: 11010616. DOI: 10.1016/j.kisu.2024.01.001.


Prevalence of kidney disease of unknown etiology in agricultural workers, Guatemala.

Arroyo G, Soto G, Garcia S, Perez-Folgar J, Bailon P, Acabal B Rev Panam Salud Publica. 2023; 47:e84.

PMID: 37266488 PMC: 10231270. DOI: 10.26633/RPSP.2023.84.